| nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
| 1 |
Algorithm for the prevention of ventricular tachycardia onset: the prevent study
|
Fromer, Martin
|
|
1999
|
83 |
5S2 |
p. 45-47
3 p.
|
artikel
|
| 2 |
Amiodarone and “primary” prevention of sudden death: critical review of a decade of clinical trials
|
Farré, Jerónimo
|
|
1999
|
83 |
5S2 |
p. 55-63
9 p.
|
artikel
|
| 3 |
A new system for catheter ablation of atrial fibrillation
|
Calkins, Hugh
|
|
1999
|
83 |
5S2 |
p. 227-236
10 p.
|
artikel
|
| 4 |
Antiarrhythmic drugs or implantable cardioverter defibrillators in heart failure: the “poor heart”
|
Böcker, Dirk
|
|
1999
|
83 |
5S2 |
p. 83-87
5 p.
|
artikel
|
| 5 |
A preview of implantable cardioverter defibrillator systems in the next millennium: an integrative cardiac rhythm management approach
|
Morris, Milton M
|
|
1999
|
83 |
5S2 |
p. 48-54
7 p.
|
artikel
|
| 6 |
Atrioventricular nodal ablation and pacemaker implantation in patients with atrial fibrillation
|
Touboul, Paul
|
|
1999
|
83 |
5S2 |
p. 241-245
5 p.
|
artikel
|
| 7 |
Beta blockers: evidence versus wishful thinking
|
Andresen, Dietrich
|
|
1999
|
83 |
5S2 |
p. 64-67
4 p.
|
artikel
|
| 8 |
Biventricular pacing in patients with congestive heart failure: two prospective randomized trials
|
Saxon, Leslie A
|
|
1999
|
83 |
5S2 |
p. 120-123
4 p.
|
artikel
|
| 9 |
Can right-sided atrioventricular sequential pacing provide benefit for selected patients with severe congestive heart failure?
|
Sack, Stefan
|
|
1999
|
83 |
5S2 |
p. 124-129
6 p.
|
artikel
|
| 10 |
Clinical significance of multiple sensor options: rate response optimization, sensor blending, and trending
|
Clémenty, Jacques
|
|
1999
|
83 |
5S2 |
p. 166-171
6 p.
|
artikel
|
| 11 |
Combining nonpharmacologic therapies for advanced heart failure: the münster experience with the assist device–defibrillator combination
|
Deng, Mario C
|
|
1999
|
83 |
5S2 |
p. 158-160
3 p.
|
artikel
|
| 12 |
Effect of pacing mode on morbidity and mortality: update of clinical pacing trials
|
McComb, Janet M
|
|
1999
|
83 |
5S2 |
p. 211-213
3 p.
|
artikel
|
| 13 |
Energy levels for defibrillation: what is of real clinical importance?
|
Fotuhi, Parwis C
|
|
1999
|
83 |
5S2 |
p. 24-33
10 p.
|
artikel
|
| 14 |
Evolving indications for permanent pacing
|
Hayes, David L
|
|
1999
|
83 |
5S2 |
p. 161-165
5 p.
|
artikel
|
| 15 |
Future of bradyarrhythmia therapy systems: automaticity
|
Jones, Bruce R
|
|
1999
|
83 |
5S2 |
p. 192-201
10 p.
|
artikel
|
| 16 |
Has the survival of the heart failure population changed? lessons from trials
|
Cleland, JohnG.F
|
|
1999
|
83 |
5S2 |
p. 112-119
8 p.
|
artikel
|
| 17 |
How smart should pacemakers be?
|
Saoudi, Nadir
|
|
1999
|
83 |
5S2 |
p. 180-186
7 p.
|
artikel
|
| 18 |
Impact of the multicenter automatic defibrillator implantation trial on implantable cardioverter defibrillator indication trends
|
Higgins, Steven L
|
|
1999
|
83 |
5S2 |
p. 79-82
4 p.
|
artikel
|
| 19 |
Introduction
|
Breithardt, Günter
|
|
1999
|
83 |
5S2 |
p. 1-4
4 p.
|
artikel
|
| 20 |
Is inappropriate therapy a resolved issue with current implantable cardioverter defibrillators?
|
Brugada, Josep
|
|
1999
|
83 |
5S2 |
p. 40-44
5 p.
|
artikel
|
| 21 |
Managing atrial tachyarrhythmias in patients with implantable cardioverter defibrillators
|
Schaumann, Anselm
|
|
1999
|
83 |
5S2 |
p. 214-217
4 p.
|
artikel
|
| 22 |
Mode switching for atrial tachyarrhythmias
|
Sutton, Richard
|
|
1999
|
83 |
5S2 |
p. 202-210
9 p.
|
artikel
|
| 23 |
Multisite or alternate site pacing for the prevention of atrial fibrillation
|
Ramdat Misier, Anand R
|
|
1999
|
83 |
5S2 |
p. 237-240
4 p.
|
artikel
|
| 24 |
Navigation in the mega-trials waters: reflections on the multicenter automatic defibrillator implantation trial and the antiarrhythmics versus implantable defibrillators study
|
Farré, Jerónimo
|
|
1999
|
83 |
5S2 |
p. 5-7
3 p.
|
artikel
|
| 25 |
New primary prevention trials of sudden cardiac death in patients with left ventricular dysfunction: SCD-HEFT and MADIT-II
|
Klein, Helmut
|
|
1999
|
83 |
5S2 |
p. 91-97
7 p.
|
artikel
|
| 26 |
Pacemaker leads: performance and progress
|
de Voogt, Willem G
|
|
1999
|
83 |
5S2 |
p. 187-191
5 p.
|
artikel
|
| 27 |
Potential benefit of biventricular pacing in patients with congestive heart failure and ventricular tachyarrhythmia
|
Stellbrink, Christoph
|
|
1999
|
83 |
5S2 |
p. 143-150
8 p.
|
artikel
|
| 28 |
Safety and efficacy of implantable defibrillator therapy with programmed shock energy at twice the augmented step-down defibrillation threshold: results of the prospective, randomized, multicenter low-energy endotak trial
|
Neuzner, Joerg
|
|
1999
|
83 |
5S2 |
p. 34-39
6 p.
|
artikel
|
| 29 |
Secondary prevention of sudden death: the Dutch study, the antiarrhythmics versus implantable defibrillator trial, the cardiac arrest study Hamburg, and the Canadian implantable defibrillator study
|
Cappato, Riccardo
|
|
1999
|
83 |
5S2 |
p. 68-73
6 p.
|
artikel
|
| 30 |
Single-chamber versus dual-chamber implantable cardioverter defibrillators: indications and clinical results
|
Trappe, Hans-Joachim
|
|
1999
|
83 |
5S2 |
p. 8-16
9 p.
|
artikel
|
| 31 |
Taking advantage of sophisticated pacemaker diagnostics
|
Nowak, Bernd
|
|
1999
|
83 |
5S2 |
p. 172-179
8 p.
|
artikel
|
| 32 |
The atrial defibrillator: a stand-alone device or part of a combined dual-chamber system?
|
Heisel, Armin
|
|
1999
|
83 |
5S2 |
p. 218-226
9 p.
|
artikel
|
| 33 |
The implantable cardioverter defibrillator and primary prevention of sudden death: the multicenter automatic defibrillator implantation trial and the coronary artery bypass graft (CABG)-patch trial
|
Block, Michael
|
|
1999
|
83 |
5S2 |
p. 74-78
5 p.
|
artikel
|
| 34 |
The implantable cardioverter defibrillator as a “bridge to transplant”: a viable clinical strategy?
|
Schmidinger, Herwig
|
|
1999
|
83 |
5S2 |
p. 151-157
7 p.
|
artikel
|
| 35 |
The pacing therapies for congestive heart failure (PATH-CHF) study: rationale, design, and endpoints of a prospective randomized multicenter study1 1 For a complete list of institutions and individuals participating in the PATH-CHF Study Group, see the Appendix.
|
Auricchio, Angelo
|
|
1999
|
83 |
5S2 |
p. 130-135
6 p.
|
artikel
|
| 36 |
The problem of out-of-hospital cardiac-arrest prevalence of sudden death in Europe today
|
Holmberg, Mikael
|
|
1999
|
83 |
5S2 |
p. 88-90
3 p.
|
artikel
|
| 37 |
Transvenous biventricular pacing for heart failure: can the obstacles be overcome?
|
Auricchio, Angelo
|
|
1999
|
83 |
5S2 |
p. 136-142
7 p.
|
artikel
|
| 38 |
Use of the prophylactic implantable cardioverter defibrillator for patients with normal hearts
|
Brugada, Pedro
|
|
1999
|
83 |
5S2 |
p. 98-100
3 p.
|
artikel
|
| 39 |
What is the ideal rate-adaptive sensor for patients with implantable cardioverter defibrillators: lessons from cardiac pacing
|
Alt, Eckhard
|
|
1999
|
83 |
5S2 |
p. 17-23
7 p.
|
artikel
|
| 40 |
What risk should justify implantable cardioverter defibrillator therapy?
|
Schläpfer, J
|
|
1999
|
83 |
5S2 |
p. 101-103
3 p.
|
artikel
|
| 41 |
Which strategy is “best” after myocardial infarction? the beta-blocker strategy plus implantable cardioverter defibrillator trial: rationale and study design1 1 This work was sponsored by Guidant Italia, S.r.l., Milan, Italy. Data coordination by INNOVEX s.r.l., Milan, Italy. For a complete list of steering committee members and participating centers, see Appendix.
|
Raviele, Antonio
|
|
1999
|
83 |
5S2 |
p. 104-111
8 p.
|
artikel
|
Tijdschrift beschrijving